We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    C16011
Previous Study | Return to List | Next Study

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

This study is currently recruiting participants.
Verified June 2017 by Takeda ( Millennium Pharmaceuticals, Inc. )
Sponsor:
ClinicalTrials.gov Identifier:
NCT01659658
First Posted: August 8, 2012
Last Update Posted: June 9, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 1, 2018
  Estimated Primary Completion Date: September 1, 2018 (Final data collection date for primary outcome measure)